Cerebral Toxoplasmosis as the Presenting Manifestation of HIV/AIDS

被引:0
作者
Oguz-Ayarci, Ayse [1 ]
Mistik, Resit [1 ]
Akin, Hicran [1 ]
Hakyemez, Bahattin [2 ]
Helvaci, Safiye [1 ]
Akalin, Halis [1 ]
Oral, Barbaros [1 ]
机构
[1] Uludag Univ, Tip Fakultesi, Infeksiyon Hastaliklari & Klin Mikrobiyol Anabil, Bursa, Turkey
[2] Uludag Univ, Tip Fakultesi, Radyol Anabilim Dali, Bursa, Turkey
关键词
Cerebral toxoplasmosis; HIV/AIDS;
D O I
10.5152/kd.2011.13
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During the course of HIV infection, opportunistic infections are common. Toxoplasmosis is an opportunistic infection that can cause encephalitis and intracerebral mass lesions in HIV/AIDS patients. We report a previously healthy 41-year-old man with balance disorder due to cerebral toxoplasmosis as the presenting manifestation of HIV/AIDS.
引用
收藏
页码:62 / 64
页数:3
相关论文
共 13 条
[1]   Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy [J].
Antinori, A ;
Larussa, D ;
Cingolani, A ;
Lorenzini, P ;
Bossolasco, S ;
Finazzi, MG ;
Bongiovanni, M ;
Guaraldi, G ;
Grisetti, S ;
Vigo, B ;
Gigli, B ;
Mariano, A ;
Dalle Nogare, ER ;
De Marco, M ;
Moretti, F ;
Corsi, P ;
Abrescia, N ;
Rellecati, P ;
Castagna, A ;
Mussini, C ;
Ammassari, A ;
Cinque, P ;
Monforte, AD .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (11) :1681-1691
[2]  
Cleghorn FR, 2005, MANDELL DOUGLAS BENN, P2119
[3]   TREATMENT OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS - A RANDOMIZED TRIAL COMPARING PYRIMETHAMINE PLUS CLINDAMYCIN TO PYRIMETHAMINE PLUS SULFADIAZINE [J].
DANNEMANN, B ;
MCCUTCHAN, JA ;
ISRAELSKI, D ;
ANTONISKIS, D ;
LEPORT, C ;
LUFT, B ;
NUSSBAUM, J ;
CLUMECK, N ;
MORLAT, P ;
CHIU, J ;
VILDE, JL ;
ORELLANA, M ;
FEIGAL, D ;
BARTOK, A ;
HESELTINE, P ;
LEEDOM, J ;
REMINGTON, J .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (01) :33-43
[4]  
Jones J L, 1999, MMWR CDC Surveill Summ, V48, P1
[5]   Pyrimethamine-clindamycin vs pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS [J].
Katlama, C ;
DeWit, S ;
ODoherty, E ;
VanGlabeke, M ;
Clumeck, N ;
Payen, MC ;
Mathiesen, L ;
Nielsen, JO ;
Pedersen, C ;
Dupont, B ;
Pialoux, G ;
Janbon, F ;
Reynes, J ;
Gallais, H ;
Mars, ME ;
Jeantils, V ;
Schneider, MC ;
Averous, V ;
Decazes, JM ;
DocoLecompte, T ;
Modai, J ;
Molina, JM ;
Blanc, A ;
Delfraissy, JF ;
Guillevin, L ;
Jarrousse, B ;
Sehouane, R ;
Trogoff, B ;
Armengaud, M ;
Marchou, B ;
Meurisse, JJ ;
Gentilini, M ;
Guichard, A ;
Rogeaux, O ;
Livrozet, JM ;
Touraine, JL ;
Sereni, D ;
Rousseau, F ;
Pesce, A ;
Coulaud, JP ;
Detruchis, P ;
Fegueux, S ;
Maslo, C ;
Matheron, S ;
Raffi, F ;
Bassetti, D ;
Canessa, A ;
DelBono, V ;
DeLeo, P ;
Terragna, A .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (02) :268-275
[6]  
LEVY RM, 1988, J ACQ IMMUN DEF SYND, V1, P41
[7]   TOXOPLASMIC ENCEPHALITIS IN AIDS [J].
LUFT, BJ ;
REMINGTON, JS .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (02) :211-222
[8]  
Montoya JG KJ, 2005, PRINCIPLES PRACTICE, V6th, P3170
[9]   CEREBRAL TOXOPLASMOSIS COMPLICATING THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME - CLINICAL AND NEUROPATHOLOGICAL FINDINGS IN 27 PATIENTS [J].
NAVIA, BA ;
PETITO, CK ;
GOLD, JWM ;
CHO, FS ;
JORDAN, BD ;
PRICE, RW .
ANNALS OF NEUROLOGY, 1986, 19 (03) :224-238
[10]   TOXOPLASMA ENCEPHALITIS IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
RENOLD, C ;
SUGAR, A ;
CHAVE, JP ;
PERRIN, L ;
DELAVELLE, J ;
PIZZOLATO, G ;
BURKHARD, P ;
GABRIEL, V ;
HIRSCHEL, B .
MEDICINE, 1992, 71 (04) :224-239